| 000 | 01805 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517104747.0 | ||
| 264 | 0 | _c20170524 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/bjc.2016.203 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVaidyanathan, Aparajitha | |
| 245 | 0 | 0 |
_aABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _c08 2016 |
||
| 300 |
_a431-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAcridines _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xtherapeutic use |
| 650 | 0 | 4 |
_aPhthalazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aTetrahydroisoquinolines _xpharmacology |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _aSawers, Lynne | |
| 700 | 1 | _aGannon, Anne-Louise | |
| 700 | 1 | _aChakravarty, Probir | |
| 700 | 1 | _aScott, Alison L | |
| 700 | 1 | _aBray, Susan E | |
| 700 | 1 | _aFerguson, Michelle J | |
| 700 | 1 | _aSmith, Gillian | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 115 _gno. 4 _gp. 431-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.2016.203 _zAvailable from publisher's website |
| 999 |
_c26226385 _d26226385 |
||